ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Modified Severity Weighted Assessment Tool for Mycosis Fungoides and Sezary Syndrome

Modified Severity Weighted Assessment Tool for Mycosis Fungoides and Sezary Syndrome
Body region Percent BSA in body region Assessment of involvement in patient's skin
Patch* Plaque TumorΔ
Head 7      
Neck 2      
Anterior trunk 13      
Arms 8      
Forearms 6      
Hands 5      
Posterior trunk 13      
Buttocks 5      
Thighs 19      
Legs 14      
Feet 7      
Groin 1      
Subtotal of lesion BSA:        
Weighting factor:   x1 x2 x4
Subtotal lesion BSA x weighting factor:        
Modified Severity Weighted Assessment Tool score equals summation of each column line.
BSA: body surface area; mSWAT: modified Severity Weighted Assessment Tool.
* Any size lesion without induration or significant elevation above the surrounding uninvolved skin; poikiloderma may be present.
¶ Any size lesion that is elevated or indurated; crusting, ulceration, or poikiloderma may be present.
Δ Any solid or nodular lesion ≥1 cm in diameter with evidence of deep infiltration in the skin and/or vertical growth.
From: Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol; 29(18), 2011:2598-2607. Reprinted with permission. Copyright © 2011 American Society of Clinical Oncology. All rights reserved.
Graphic 83963 Version 2.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟